Immunotherapy for malignant tumors with focus on toll‐like receptors
Oral Science International · 2019
DOI: 10.1002/osi2.1011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Science International, 2019. Verfasst von Yoko Manome und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Grant-in-Aid for Scientific Research (C) from JSPS, Private University Research Branding Project from MEXT, Grant-in-Aid for Challenging Exploratory Research from JSPS.
Abstract (Originalsprache)
One in three Japanese people will develop cancer during their lifetime and cancer is the leading cause of death in Japan, with prognosis known to worsen with development of distant metastasis. Recently, immunotherapy treatment for cancer has become established and shown to be more effective with fewer side effects as compared to other therapeutic options. As a result, toll‐like receptors (TLRs), which recognize molecules derived from many types of pathogens and activate the intra‐vital immune system, have become new targets for cancer immunotherapy treatment. In the present review, we provide an outline of immunotherapy procedures with a focus on TLRs.
Förderung
- Grant-in-Aid for Scientific Research (C) from JSPS
- Private University Research Branding Project from MEXT
- Grant-in-Aid for Challenging Exploratory Research from JSPS
- MEXT-Supporting Program for the Strategic Research Foundation at Private Universities
Zitieren
APA
Manome, Y., Suzuki, D., Nishida, R., Yamada, A., Miyamoto, Y., Funatsu, T., & Kamijo, R. (2019). Immunotherapy for malignant tumors with focus on toll‐like receptors. Oral Science International. https://doi.org/10.1002/osi2.1011
Vancouver
Manome Y, Suzuki D, Nishida R, Yamada A, Miyamoto Y, Funatsu T, et al. Immunotherapy for malignant tumors with focus on toll‐like receptors. Oral Science International. 2019. doi:10.1002/osi2.1011
BibTeX
@article{Manome2019,
author = {Manome, Yoko and Suzuki, Dai and Nishida, Rie and Yamada, Atsushi and Miyamoto, Yoichi and Funatsu, Takahiro and Kamijo, Ryutaro},
title = {Immunotherapy for malignant tumors with focus on toll‐like receptors},
journal = {Oral Science International},
year = {2019},
doi = {10.1002/osi2.1011}
}
EUVIMED